BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 27992874)

  • 1. Differential Expression of Lipoprotein-Associated Phospholipase A2 in Monocyte Subsets: Impact of Uremia and Atherosclerosis.
    Ulrich C; Trojanowicz B; Fiedler R; Kohler F; Wolf AF; Seibert E; Girndt M
    Nephron; 2017; 135(3):231-241. PubMed ID: 27992874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interpretation of lipoprotein-associated phospholipase A2 levels is influenced by cardiac disease, comorbidities, extension of atherosclerosis and treatments.
    Charniot JC; Khani-Bittar R; Albertini JP; Giral P; Cherfils C; Cosson C; Guillerm E; Leprince P; Gandjbakhch I; Bonnefont-Rousselot D
    Int J Cardiol; 2013 Sep; 168(1):132-8. PubMed ID: 23103135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of lipoprotein-associated phospholipase A2 in atherosclerosis may depend on its lipoprotein carrier in plasma.
    Tellis CC; Tselepis AD
    Biochim Biophys Acta; 2009 May; 1791(5):327-38. PubMed ID: 19272461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Lipoprotein-associated Phospholipase A2 in Serum in Patients With Stage 3-5 Chronic Kidney Disease.
    Wang Y; Li SS; Na SP; Yu CY; Ji Y; Zhao SL; Xie RJ; Bao YS
    Am J Med Sci; 2016 Oct; 352(4):348-353. PubMed ID: 27776715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lentiviral-mediated RNA interference of lipoprotein-associated phospholipase A2 ameliorates inflammation and atherosclerosis in apolipoprotein E-deficient mice.
    Zhang H; Zhang J; Shen D; Zhang L; He F; Dang Y; Li L
    Int J Mol Med; 2013 Mar; 31(3):651-9. PubMed ID: 23338278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Darapladib, a Lipoprotein-Associated Phospholipase A2 Inhibitor, Reduces Rho Kinase Activity in Atherosclerosis.
    Zhang J; Xu DL; Liu XB; Bi SJ; Zhao T; Sui SJ; Ji XP; Lu QH
    Yonsei Med J; 2016 Mar; 57(2):321-7. PubMed ID: 26847282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein-associated phospholipase A2 (Lp-PLA2) and tumor necrosis factor-alpha (TNF-α) and their relation to premature atherosclerosis in β-thalassemia children.
    Ragab SM; Safan MA; Obeid OM; Sherief AS
    Hematology; 2015 May; 20(4):228-38. PubMed ID: 25056687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein-associated phospholipase A₂ activity is increased in patients with definite familial hypercholesterolemia compared with other forms of hypercholesterolemia.
    Mattina A; Rosenbaum D; Bittar R; Bonnefont-Rousselot D; Noto D; Averna M; Bruckert E; Giral P
    Nutr Metab Cardiovasc Dis; 2018 May; 28(5):517-523. PubMed ID: 29525223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study.
    Ballantyne CM; Hoogeveen RC; Bang H; Coresh J; Folsom AR; Chambless LE; Myerson M; Wu KK; Sharrett AR; Boerwinkle E
    Arch Intern Med; 2005 Nov; 165(21):2479-84. PubMed ID: 16314544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. OxLDL stimulates lipoprotein-associated phospholipase A2 expression in THP-1 monocytes via PI3K and p38 MAPK pathways.
    Wang WY; Li J; Yang D; Xu W; Zha RP; Wang YP
    Cardiovasc Res; 2010 Mar; 85(4):845-52. PubMed ID: 19910444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein-associated phospholipase A2 is related to risk of subclinical atherosclerosis but is not supported by Mendelian randomization analysis in a general Japanese population.
    Ueshima H; Kadowaki T; Hisamatsu T; Fujiyoshi A; Miura K; Ohkubo T; Sekikawa A; Kadota A; Kadowaki S; Nakamura Y; Miyagawa N; Okamura T; Kita Y; Takashima N; Kashiwagi A; Maegawa H; Horie M; Yamamoto T; Kimura T; Kita T;
    Atherosclerosis; 2016 Mar; 246():141-7. PubMed ID: 26775119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High density lipoprotein suppresses lipoprotein associated phospholipase A2 in human monocytes-derived macrophages through peroxisome proliferator-activated receptor-γ pathway.
    Han GP; Ren JY; Qin L; Song JX; Wang L; Chen H
    Chin Med J (Engl); 2012 Dec; 125(24):4474-80. PubMed ID: 23253723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between high-sensitivity C-reactive protein, lipoprotein-associated phospholipase A2 and carotid atherosclerosis: A cross-sectional study.
    Liu H; Yao Y; Wang Y; Ji L; Zhu K; Hu H; Chen J; Yang J; Cui Q; Geng B; Liu Q; Li D; Zhou Y
    J Cell Mol Med; 2018 Oct; 22(10):5145-5150. PubMed ID: 30094934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein profile, lipoprotein-associated phospholipase A2 and cardiovascular risk in hemodialysis patients.
    Rolla R; De Mauri A; Valsesia A; Vidali M; Chiarinotti D; Bellomo G
    J Nephrol; 2015 Dec; 28(6):749-55. PubMed ID: 25971848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of lipoprotein-associated phospholipase A2 mass with asymptomatic cerebral artery stenosis.
    Wang Y; Zhou B; Zhou P; Yao Y; Cui Q; Liu Y; Yang J; Wu S; Zhao X; Zhou Y
    J Cell Mol Med; 2018 Apr; 22(4):2329-2336. PubMed ID: 29424477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Does Lp-PLA2 determination help predict atherosclerosis and cardiocerebrovascular disease?].
    Sertić J; Skorić B; Lovrić J; Bozina T; Reiner Z
    Acta Med Croatica; 2010 Oct; 64(4):237-45. PubMed ID: 21688606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of lipoprotein-associated phospholipase A2 in leukocyte activation and inflammatory responses.
    Shi Y; Zhang P; Zhang L; Osman H; Mohler ER; Macphee C; Zalewski A; Postle A; Wilensky RL
    Atherosclerosis; 2007 Mar; 191(1):54-62. PubMed ID: 16765356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein-associated phospholipase A2 is elevated in patients with severe aortic valve stenosis without clinically overt atherosclerosis.
    Kolasa-Trela R; Fil K; Bazanek M; Grudzień G; Sobczyk D; Sadowski J; Undas A
    Clin Chem Lab Med; 2012 Oct; 50(10):1825-31. PubMed ID: 23089713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Community-based statins and advanced carotid plaque: Role of CD163 positive macrophages in lipoprotein-associated phospholipase A
    Otsuka F; Zhao X; Trout HH; Qiao Y; Wasserman BA; Nakano M; Macphee CH; Brandt M; Krug-Gourley S; Guo L; Ladich ER; Cheng Q; Davis HR; Finn AV; Virmani R; Kolodgie FD
    Atherosclerosis; 2017 Dec; 267():78-89. PubMed ID: 29101839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local production of lipoprotein-associated phospholipase A2 and lysophosphatidylcholine in the coronary circulation: association with early coronary atherosclerosis and endothelial dysfunction in humans.
    Lavi S; McConnell JP; Rihal CS; Prasad A; Mathew V; Lerman LO; Lerman A
    Circulation; 2007 May; 115(21):2715-21. PubMed ID: 17502572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.